Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: a randomised, controlled trial with long-term follow-up

Overview of attention for article published in European Journal of Cancer (1965), January 2005

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

So far, Altmetric has seen 1 news story.

For premenopausal women with estrogen receptor (ER)-positive breast cancer, 2 years of adjuvant tamoxifen is enough to confer a…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.